Karuna Therapeutics - Ownership and Business Overview

Life ScienceCompany

Karuna Therapeutics Ownership

Who owns Karuna Therapeutics?

Karuna Therapeutics is owned by Bristol-Myers Squibb. It was acquired on December 22, 2023.

Karuna Therapeutics Business Overview

Where is Karuna Therapeutics headquartered?

Karuna Therapeutics is headquartered in Boston, Massachusetts.

What is Karuna Therapeutics’ revenue?

Karuna Therapeutics disclosed revenue of 11M USD for 2022 and 37M USD for 2021.

What sector is Karuna Therapeutics in?

Karuna Therapeutics is a life science company.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 206 acquisitions of life science companies in 2023, including 27 acquisitions by private equity firms, and 179 by strategics.

Karuna Therapeutics

Karuna Therapeutics, Inc.

99 High St. Floor 26,
Boston, Massachusetts 02110
United States,
(857) 449-2244
www.karunatx.com

Karuna Therapeutics is a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions. Karuna Therapeutics is based in Boston, Massachusetts.


 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.